Regatta Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$718K Buy
1,433
+45
+3% +$21.6K 0.1% 118
2026
Q1
$682K Buy
1,388
+119
+9% +$64.6K 0.1% 115
2025
Q4
$735K Hold
1,269
0.11% 114
2025
Q3
$615K Buy
1,269
+4
+0.3% +$1.86K 0.1% 126
2025
Q2
$513K Buy
1,265
+18
+1% +$7.53K 0.09% 135
2025
Q1
$621K Hold
1,247
0.12% 107
2024
Q4
$649K Sell
1,247
-4
-0.3% -$2.2K 0.13% 105
2024
Q3
$774K Buy
1,251
+4
+0.3% +$2.37K 0.15% 95
2024
Q2
$690K Hold
1,247
0.15% 98
2024
Q1
$725K Sell
1,247
-5
-0.4% -$2.81K 0.16% 92
2023
Q4
$665K Buy
1,252
+5
+0.4% +$2.42K 0.17% 88
2023
Q3
$631K Hold
1,247
0.2% 84
2023
Q2
$651K Sell
1,247
-10
-0.8% -$5.4K 0.21% 87
2023
Q1
$692K Hold
1,257
0.25% 90
2022
Q4
$692K Buy
1,257
+512
+69% +$271K 0.25% 90
2022
Q3
$405K Hold
745
0.17% 106
2022
Q2
$405K Hold
745
0.19% 98
2022
Q1
$440K Hold
745
0.15% 113
2021
Q4
$497K Buy
+745
New +$465K 0.17% 103

Other funds holding TMO

Regatta Capital Group's TMO Position: Q2 2026 in Review

Regatta Capital Group increased its Thermo Fisher Scientific (TMO) stake by 3.2% in Q2 2026, buying an estimated $21.6K and bringing the position to 1,433 shares worth $718K. The position accounts for 0.1% of the portfolio, ranked #118.

Regatta Capital Group first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $774K in Q3 2024. 2,626 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Regatta Capital Group held 1,433 shares of Thermo Fisher Scientific worth $718K as of Q2 2026.
  • Regatta Capital Group bought 45 Thermo Fisher Scientific shares in Q2 2026, an estimated $21.6K.
  • Thermo Fisher Scientific made up 0.1% of Regatta Capital Group's portfolio in Q2 2026, its #118 holding.
  • Regatta Capital Group first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • Regatta Capital Group's Thermo Fisher Scientific position peaked at $774K in Q3 2024.
  • 2,626 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Regatta Capital Group's 13F filing for Q2 2026, filed 12 Aug 2026.